
Karen Chotkowski
Examiner (ID: 15977)
| Most Active Art Unit | 3505 |
| Art Unit(s) | 3505 |
| Total Applications | 832 |
| Issued Applications | 716 |
| Pending Applications | 8 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20534458
[patent_doc_number] => 12551509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Acellular regenerative products and methods of their manufacture
[patent_app_type] => utility
[patent_app_number] => 16/043520
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7150
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16043520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/043520 | Acellular regenerative products and methods of their manufacture | Jul 23, 2018 | Issued |
Array
(
[id] => 15898961
[patent_doc_number] => 20200148999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => CELL CULTERING MATERIALS
[patent_app_type] => utility
[patent_app_number] => 16/630872
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630872 | Cell culturing materials | Jul 5, 2018 | Issued |
Array
(
[id] => 16855160
[patent_doc_number] => 20210155905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Method for Obtaining Haploid Cells
[patent_app_type] => utility
[patent_app_number] => 16/625834
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625834
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625834 | Method for Obtaining Haploid Cells | Jul 1, 2018 | Pending |
Array
(
[id] => 13508253
[patent_doc_number] => 20180305669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => MICROTISSUE FORMATION USING STEM CELL-DERIVED HUMAN HEPATOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/023685
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023685 | MICROTISSUE FORMATION USING STEM CELL-DERIVED HUMAN HEPATOCYTES | Jun 28, 2018 | Abandoned |
Array
(
[id] => 16466747
[patent_doc_number] => 20200368284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => ANGIOPOIETIN-1- OR VEGF-SECRETING STEM CELL AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE, COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/623868
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623868 | ANGIOPOIETIN-1- OR VEGF-SECRETING STEM CELL AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE, COMPRISING SAME | Jun 18, 2018 | Abandoned |
Array
(
[id] => 16091109
[patent_doc_number] => 20200199541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => BLOOD VESSEL ORGANOID, METHODS OF PRODUCING AND USING SAID ORGANOIDS
[patent_app_type] => utility
[patent_app_number] => 16/623319
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623319 | BLOOD VESSEL ORGANOID, METHODS OF PRODUCING AND USING SAID ORGANOIDS | Jun 14, 2018 | Pending |
Array
(
[id] => 16091083
[patent_doc_number] => 20200199528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => CELL CULTURE MEDIA FOR DIFFERENTIATION OF STEM CELLS INTO HEPATOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/622337
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622337 | CELL CULTURE MEDIA FOR DIFFERENTIATION OF STEM CELLS INTO HEPATOCYTES | Jun 14, 2018 | Abandoned |
Array
(
[id] => 16375080
[patent_doc_number] => 20200323922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHOD FOR TREATING A SIDE EFFECT OF IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/621886
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621886 | METHOD FOR TREATING A SIDE EFFECT OF IMMUNOTHERAPY | Jun 12, 2018 | Abandoned |
Array
(
[id] => 15866839
[patent_doc_number] => 20200140823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHODS FOR EXPANDING HEMATOPOIETIC STEM CELLS USING REVITALIZED MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/620839
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620839 | Methods for expanding hematopoietic stem cells using revitalized mesenchymal stem cells | Jun 6, 2018 | Issued |
Array
(
[id] => 16901107
[patent_doc_number] => 20210180023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => CARDIAC REPAIR BY REPROGRAMMING OF ADULT CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/639523
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -85
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639523 | CARDIAC REPAIR BY REPROGRAMMING OF ADULT CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES | Jun 3, 2018 | Abandoned |
Array
(
[id] => 13402323
[patent_doc_number] => 20180252704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => SCREENING ASSAY TO IDENTIFY IDO1 AND/OR TDO MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/973837
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15973837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/973837 | SCREENING ASSAY TO IDENTIFY IDO1 AND/OR TDO MODULATORS | May 7, 2018 | Abandoned |
Array
(
[id] => 15646691
[patent_doc_number] => 20200085875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => PLATELET VESICLE-ENGINEERED CELLS FOR TARGETED TISSUE REPAIR
[patent_app_type] => utility
[patent_app_number] => 16/604680
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604680 | PLATELET VESICLE-ENGINEERED CELLS FOR TARGETED TISSUE REPAIR | Apr 19, 2018 | Abandoned |
Array
(
[id] => 13508467
[patent_doc_number] => 20180305776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => MYC-REPORTERS, CELLS CONTAINING MYC-REPORTERS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/957816
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957816 | MYC-REPORTERS, CELLS CONTAINING MYC-REPORTERS AND METHODS OF USE THEREOF | Apr 18, 2018 | Abandoned |
Array
(
[id] => 13357789
[patent_doc_number] => 20180230434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => METHODS OF PREPARING A PRIMARY CELL SAMPLE
[patent_app_type] => utility
[patent_app_number] => 15/950739
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15950739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/950739 | Methods of preparing a primary cell sample | Apr 10, 2018 | Issued |
Array
(
[id] => 16778327
[patent_doc_number] => 20210115405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Method For Obtaining Differentiated Cells From Muscle Derived Progenitor Cells
[patent_app_type] => utility
[patent_app_number] => 16/604796
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604796 | Method For Obtaining Differentiated Cells From Muscle Derived Progenitor Cells | Apr 8, 2018 | Abandoned |
Array
(
[id] => 15290683
[patent_doc_number] => 20190388477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF A PERFUSION DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/311633
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311633
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311633 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF A PERFUSION DISORDER | Feb 20, 2018 | Abandoned |
Array
(
[id] => 15145103
[patent_doc_number] => 20190351029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => MODULATION OF ISCHEMIC CELL BIOENERGETICS
[patent_app_type] => utility
[patent_app_number] => 16/469608
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469608 | MODULATION OF ISCHEMIC CELL BIOENERGETICS | Feb 12, 2018 | Abandoned |
Array
(
[id] => 12905056
[patent_doc_number] => 20180193527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => Biomimetic Scaffolds Including Devitalized Cells
[patent_app_type] => utility
[patent_app_number] => 15/861124
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861124 | Biomimetic Scaffolds Including Devitalized Cells | Jan 2, 2018 | Pending |
Array
(
[id] => 16206856
[patent_doc_number] => 20200239846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PROCESS OF PREPARING CHONDROCYTE CELL SUSPENSION AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 15/761392
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761392
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761392 | PROCESS OF PREPARING CHONDROCYTE CELL SUSPENSION AND ITS USE | Nov 29, 2017 | Abandoned |
Array
(
[id] => 15342613
[patent_doc_number] => 20200009198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => PHARMACEUTICAL COMPOSTION CONTAINING MITOCHONDRIA
[patent_app_type] => utility
[patent_app_number] => 16/464928
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464928 | PHARMACEUTICAL COMPOSTION CONTAINING MITOCHONDRIA | Nov 27, 2017 | Abandoned |